2. Gene
  3. ATF2 - activating transcription factor 2 Gene

ATF2 - activating transcription factor 2 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Canis lupus familiaris (sub-species: familiaris)
Gene ID: 478806 | Gene type: protein coding

About ATF2

ATF2 Products(15)

mRNA Protein Name
XM_038447132.1 XP_038303060.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447122.1 XP_038303050.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447125.1 XP_038303053.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447127.1 XP_038303055.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447126.1 XP_038303054.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447124.1 XP_038303052.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447123.1 XP_038303051.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447128.1 XP_038303056.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447131.1 XP_038303059.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447130.1 XP_038303058.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447129.1 XP_038303057.1 cyclic AMP-dependent transcription factor ATF-2 isoform X1
XM_038447133.1 XP_038303061.1 cyclic AMP-dependent transcription factor ATF-2 isoform X2
XM_038447135.1 XP_038303063.1 cyclic AMP-dependent transcription factor ATF-2 isoform X2
XM_038447134.1 XP_038303062.1 cyclic AMP-dependent transcription factor ATF-2 isoform X2
XM_038447136.1 XP_038303064.1 cyclic AMP-dependent transcription factor ATF-2 isoform X3
Protein Preferred Names Protein Names

cyclic AMP-dependent transcription factor ATF-2

mutant activating transcription factor 2

Related Agents

Approval
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B1198 Piperonyl butoxide Inhibitor 98.0% Unkown
HY-B1198R Piperonyl butoxide (Standard) Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-13241 Ralimetinib dimesylate 99.97% Phase 2
HY-13241A Ralimetinib Inhibitor 98.58% Phase 2
Pre-clinical Phase
Bioactive Molecules (11)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-152860 Darizmetinib 99.94% Unkown
HY-134963 SBI-0087702 99.55% Unkown
HY-117987 CPS-11 99.39% Unkown
HY-RS01128 ATF2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-B1198S Piperonyl butoxide-d9 Inhibitor / Unkown
HY-180419 SF-3-030 / Unkown
HY-RS05361 GDNF Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-107091R Aspartyl-alanyl-diketopiperazine (Standard) Inhibitor / Unkown
HY-RS17003 Atf2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23446 Atf2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W585976 Benzo[a]pyrene diol epoxide / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens ATF2 NCBI NCBI:1386